Search is Powered by Google
Cancer / Oncology News

Hairdressers And Barbers Have Higher Risk Of Cancer

rate icon Editor's Choice
Main Category: Cancer / Oncology
Also Included In: Biology / Biochemistry;  Public Health;  Primary Care / General Practice
Article Date: 29 Mar 2008 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:4 stars

3.83 (6 votes)

Health Professional:4 stars

3.75 (4 votes)

Article Opinions: 0 posts

Work as a hairdresser or barber has been confirmed as a potential carcinogenic influcence, according to a Working Group report of the International Agency for Research on Cancer (IARC), as published in the April 2008 issue of The Lancet Oncology.

Hair dyes are presently classified as permanent, semipermanent, or temporary dyes. The permanent (also called oxidative) dyes represent approximately 80% of the available products. They work by combining two chemical agents -- an intermediate and a coupler -- which are bound in the presence of peroxide to form the dye molecule. Dark dyes tend to contain the highest concentrations of these coloring ingredients. In the 1970s, after positive cancer tests in rodents, the use of some of these colorants was discontinued.

According to Dr Robert Baan, of the International Agency for Research on Cancer, Lyon, France, and colleagues, many new epidemiological studies on cancer in hairdressers, beauticians, and barbers have been published since 1993, the date of the last IARC assessment. "A small, but consistent, risk of bladder cancer was reported in male hairdressers and barbers. Because of few supporting findings by duration or period of exposure, the Working Group considered these data as limited evidence of carcinogenicity and re-affirmed occupational exposures of hairdressers and barbers as 'probably carcinogenic to humans'."

They also reviewed the epidemiological studies on the personal use of hair dyes, but this evidence was not adequate for a definitive conclusion about such treatments.

Many other chemicals, like hair dyes, belong to the group of organic molecules known as aromatic amines. Ortho-toluidine, used in many organic production processes including for hair dyes, pigments, and rubber chemicals, is now classified as carcinogenic to humans. Another curing agent, MOCA, which is used as a curing agent in plastics, also has joined this classification.

Carcinogenicity of some aromatic amines, organic dyes, and related exposures
Robert Baan, Kurt Straif, Yann Grosse,Beatrice Secretan, Fatiha El Ghissassi, Veronique Bouvard, Lamia Benbrahim-Tallaa, Vincent Cogliano
The Lancet Oncology, Vol 9, April 2008
Click Here For News Article

Written by Anna Sophia McKenney
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...